These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The late endosome-resident lipid bis(monoacylglycero)phosphate is a cofactor for Lassa virus fusion. Markosyan RM, Marin M, Zhang Y, Cohen FS, Melikyan GB. PLoS Pathog; 2021 Sep 02; 17(9):e1009488. PubMed ID: 34492091 [Abstract] [Full Text] [Related]
6. Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan. Fedeli C, Torriani G, Galan-Navarro C, Moraz ML, Moreno H, Gerold G, Kunz S. J Virol; 2018 Mar 01; 92(5):. PubMed ID: 29237830 [Abstract] [Full Text] [Related]
7. Identification of residues in Lassa virus glycoprotein 1 involved in receptor switch. Guo J, Wan Y, Liu Y, Jia X, Dong S, Xiao G, Wang W. Virol Sin; 2024 Aug 01; 39(4):600-608. PubMed ID: 38851430 [Abstract] [Full Text] [Related]
8. Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein. Shankar S, Whitby LR, Casquilho-Gray HE, York J, Boger DL, Nunberg JH. J Virol; 2016 Aug 01; 90(15):6799-807. PubMed ID: 27194767 [Abstract] [Full Text] [Related]
9. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis. Oppliger J, Torriani G, Herrador A, Kunz S. J Virol; 2016 Jul 15; 90(14):6412-6429. PubMed ID: 27147735 [Abstract] [Full Text] [Related]
10. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses. Hulseberg CE, Fénéant L, Szymańska-de Wijs KM, Kessler NP, Nelson EA, Shoemaker CJ, Schmaljohn CS, Polyak SJ, White JM. J Virol; 2019 Apr 15; 93(8):. PubMed ID: 30700611 [Abstract] [Full Text] [Related]
12. Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus. Cohen-Dvashi H, Israeli H, Shani O, Katz A, Diskin R. J Virol; 2016 Nov 15; 90(22):10329-10338. PubMed ID: 27605678 [Abstract] [Full Text] [Related]
13. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, Jia X, Zhang L, Xiao G, Wang W. J Virol; 2018 Aug 15; 92(16):. PubMed ID: 29899092 [Abstract] [Full Text] [Related]
15. Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1. Wang MK, Ren T, Liu H, Lim SY, Lee K, Honko A, Zhou H, Dyall J, Hensley L, Gartin AK, Cunningham JM. PLoS Pathog; 2018 Sep 15; 14(9):e1007322. PubMed ID: 30265711 [Abstract] [Full Text] [Related]
16. The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein. Zhang X, Tang K, Guo Y. Antiviral Res; 2020 Feb 15; 174():104701. PubMed ID: 31877348 [Abstract] [Full Text] [Related]
17. Studies of Lassa Virus Cell Entry. Pasquato A, Fernandez AH, Kunz S. Methods Mol Biol; 2018 Feb 15; 1604():135-155. PubMed ID: 28986830 [Abstract] [Full Text] [Related]